AXGN
HealthcareAxogen, Inc.
$31.76
+$0.76 (+2.45%)
Jan 5, 2026
Price History (1Y)
Analysis
Axogen, Inc. is a healthcare company specializing in medical devices. The company operates within the healthcare sector and medical device industry, with a market capitalization of $1.46 billion. Financially, Axogen reported revenue of $214.71 million for the trailing twelve months (TTM), but incurred a net loss of $2.097 million during the same period. The company's gross margin stood at 74.8%, while its operating and profit margins were 3.2% and -1.0%, respectively. Axogen generated free cash flow of $5.62 million, held $35.79 million in cash, and had a debt-to-equity ratio of 57.76. Axogen's valuation metrics include a forward price-to-earnings (P/E) ratio of 63.95, an enterprise value to earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio of 134.43, and a price-to-book ratio of 12.12. The company's revenue growth rate over the past year was 23.5%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Axogen, Inc.
Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
Visit website →Key Statistics
- Market Cap
- $1.46B
- P/E Ratio
- N/A
- 52-Week High
- $34.24
- 52-Week Low
- $9.22
- Avg Volume
- 866.31K
- Beta
- 1.00
Company Info
- Industry
- Medical Devices
- Exchange
- NCM
- Country
- United States
- Employees
- 451